DoW Tuberous Sclerosis Complex, Idea Development Award
Supports conceptually innovative, high-impact tuberous sclerosis complex research with potential to advance discoveries or patient care, open to established investigators and separate new-to-the-field applicants.
⚑ Separate competition for New-to-the-Field and Established Investigator applications · Eligibility details not fully provided in notice excerpt
Unit fits — one characterization, each unit's own rules
| IPPRA | 58 good | portfolio topic: public_health; social/behavioral work is minor; funds applied research; clinical-trial/biomedical core — IPPRA angle is policy/community (capped) |
| Physical Sciences & Engineering (demo) | 55 good | technical depth: minor; funds applied research |
| Tom Love Innovation Hub | 30 weak | funds applied research; deep-tech content |
Description
Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Idea Development Award (IDA) supports conceptually innovative and high-impact research that could ultimately lead to critical discoveries in tuberous sclerosis complex (TSC) research and/or improvements in patient care.
Distinctive Features: This funding mechanism allows for established and new-to-the-field investigators. New-to-the-field investigators are independent investigators that are early in their faculty appointments and/or established investigators transitioned from other research fields into TSC research. Applications to the New-to-the-Field option will compete separately from the Established Investigators submitting to the regular Idea Development Award (IDA).
Apply
View on Grants.gov → CONTACT: JoAnn Martin Grantor <help@eBRAP.org>